420 LEXINGTON AVENUE, NEW YORK, NY
Announces 1-for-3 Reverse Stock Split in Preparation for U.S. Stock Exchange Uplisting
Change of Auditor
Reports First Quarter 2026 Results: Robust Growth and Net Income
Announces Appointment of Torsten Greif to Board of Directors
Announces Date of Annual and Special Shareholders Meeting
Completes Buyout of Remaining Stake in Germany's Four 20 Pharma
Launches Share Repurchase Program
Announces Executive Automatic Securities Disposition Plan
Annual Report of Foreign Private Issuer Pursuant to Section 13(a) or 15(d)
Amended Annual Report of Foreign Private Issuer Pursuant to Section 13(a) or 15(d)
Notice of Exempt Offering of Securities
Effectiveness Notice
Registration Statement for Securities to be Offered to Employees
No filings found
Amended Appointment of Agent for Service of Process by Foreign Banks and Foreign Insurance Companies
Appointment of Agent for Service of Process by Foreign Banks and Foreign Insurance Companies
Registration Statement for Securities of Certain Canadian Issuers
Submission Upload
Correspondence